Cargando…
Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir
BACKGROUND/AIMS: Low-level viremia (LLV) after nucleos(t)ide analog treatment was presented as a possible cause of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). However, detailed information on patients’ adherence in the real world was lacking. This study aimed to evalua...
Autores principales: | Lee, Seung Bum, Jeong, Joonho, Park, Jae Ho, Jung, Seok Won, Jeong, In Du, Bang, Sung-Jo, Shin, Jung Woo, Park, Bo Ryung, Park, Eun Ji, Park, Neung Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364359/ https://www.ncbi.nlm.nih.gov/pubmed/32466635 http://dx.doi.org/10.3350/cmh.2020.0012 |
Ejemplares similares
-
Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis
por: Jeong, Joonho, et al.
Publicado: (2022) -
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
por: Jeon, Hee-Jeong, et al.
Publicado: (2017) -
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy
por: Park, Jung Gil, et al.
Publicado: (2015) -
Impact of cholecystectomy on acute coronary syndrome according to metabolic condition: a nationwide population-based cohort study
por: Chae, Wonjeong, et al.
Publicado: (2023) -
The role of bile carcinoembryonic antigen in diagnosing bile duct cancer.
por: Joo, Kwang Ro, et al.
Publicado: (2003)